Jameson Legal

 

Resource

 

 

 

 

 

 

 

 

 

 

 

Abbott Labs acquires IDEV Technologies for $310 million

27 Aug 2013

Jones Day advised Abbott Laboratories, a global healthcare company, in its acquisition of IDEV Technologies, Inc., a developer of endovascular stents and stent delivery systems, for $310 million in cash.

For additional information about this matter, please contact: Jonn R. Beeson, David Y. Chen

  • Client(s): Abbott Laboratories
  • Practice(s): Antitrust & Competition Law, M&A, Employee Benefits & Executive Compensation, Labor & Employment, Intellectual Property, Private Equity, Real Estate
  • Office(s): Chicago, Irvine, Silicon Valley, San Diego, London, Amsterdam, New York, Atlanta, Munich, Dallas, Düsseldorf, Washington
Matter Type
M&A: Acquiror's Counsel
Industry
Healthcare, Life Sciences & Chemicals
News Category
M&A